Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Access to Medicines
Seven recommendations for sharing intellectual property, know-how and technology – report...
Medicines Law & Policy
-
July 18, 2022
Some Surprises in the European Commission’s New Intellectual Property Strategy
Ellen 't Hoen
-
December 2, 2020
Remdesivir developed country price announced
Ellen 't Hoen
-
June 30, 2020
Covid-19 intellectual property pool gaining support
Ellen 't Hoen
-
April 23, 2020
Never say never – Why the High Income Countries that opted-out...
Christopher Garrison
-
April 8, 2020
Covid-19 and the comeback of compulsory licensing
Ellen 't Hoen
-
March 23, 2020
The Expanding Reach of the European Patent Office. Good for Health?
Ellen 't Hoen
-
March 18, 2020
Wrapping up 2019 – Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 30, 2019
Uganda tells ARIPO: No more patents for pharmaceuticals
Ellen 't Hoen
-
October 8, 2019
Corbyn’s Compulsory Licenses. Will they work?
Ellen 't Hoen
-
September 26, 2019
1
2
3
4
Page 1 of 4
This work is licensed under Creative Commons.